Corrigendum to "Effect of vitamin D3 supplementation and influence of BsmI polymorphism of VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency vitamin D3 megadose reduces inflammatory markers" [Experimental Gerontology 66 (2015) 10-16] DOI: 10.1016/j.exger.2015.03.011;Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency Vitamin D3 megadose reduces inflammatory markers.

Experimental Gerontology

Volumn 66, Issue , 2015, Pages 10-16

  Cavalcante, Isa Gabriela de Medeiros ^a   Silva, Alexandre Sérgio ^a   Costa, Maria José Carvalho ^a   Persuhn, Darlene Camati ^a   Issa, ChariraTahaMad Ibraim ^a   Freire, Tiago Lima de Luna ^b   Gonçalves, Maria da Conceição Rodrigues ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b João Pessoa City Hall ^*  (Brazil)

Author keywords

BsmI polymorphism; Elderly; Inflammation and oxidative stress; Supplementation; Vitamin D3

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM; COLECALCIFEROL; MALONALDEHYDE; OROSOMUCOID; PARATHYROID HORMONE; PLACEBO; VITAMIN D RECEPTOR; BIOLOGICAL MARKER; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN; VITAMIN D;

AGED; ARTICLE; BLOOD SAMPLING; BSMI POLYMORPHISM; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; OXIDATIVE STRESS; PARATHYROID HORMONE BLOOD LEVEL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMIN D RECEPTOR GENE; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; DRUG EFFECTS; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; CALCIUM; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; MIDDLE AGED; OXIDATIVE STRESS; PARATHYROID HORMONE; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84926391265     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2015.07.013     Document Type: Erratum

References (58)

1. Aidar M., Line S.R.P. A simple and cost-effective protocol for DNA isolation from buccal ephithelial cells. Braz. Dent. J. 2007, 18:148-152.
2. Al-Daghri N.M., Guerini F.R., Al-Attas O.S., Alokail M.S., Alkharfy K.M., Draz H.M., et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLoS One 2014, 9:e102141.
3. Arabi A., Zahed L., Mahfoud Z., El-Onsi L., Nabulsi M., Maalouf J., et al. Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls. Bone 2009, 45:1091-1097.
4. Asemi Z., Samimi M., Tabassi Z., Shakeri H., Esmaillzadeh A. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J. Nutr. 2013, 143:1432-1438.
5. Bai Y.H., Lu H., Hong D., Lin C.C., Yu Z., Chen B.C. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J. Gastroenterol. 2012, 18:1672-1679.
6. Brand-Williams W., Cuvelier M.E., Berset C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci. Technol. 1995, 28:25-30.
7. Callaway C.W., Chumlea W.C., Bouchard C., Himes J.H., Lohman T.G., Martin A.D. Circumferences. Anthropometric Standardization Reference Manual 1988, 39-54. Human Kinetics Books, Champaign. T.G. Lohman, A.F. Roche, R. Martorell (Eds.).
8. Chen Y., Zhang J., Ge X., Du J., Deb D.K., Li Y.C. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. J. Biol. Chem. 2013, 288:19450-19458.
9. Chen N., Wan Z., Han S.F., Li B.Y., Zhang Z.L., Qin L.Q. Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta analysis of randomized controlled trials. Nutrients 2014, 6:2206-2216.
10. Christakos S., Hewison M., Gardner D.G., Wagner C.L., Sergeev I.N., Rutten E., et al. Vitamin D: beyond bone. Ann. N. Y. Acad. Sci. 2013, 1287:45-58.
11. Dobnig H. A review of the health consequences of the vitamin D deficiency pandemic. Neurol. Sci. 2011, 311:15-18.
12. Elnenaei M.O., Chandra R., Mangion T., Moniz C. Genomic and metabolic patterns segregate with responses to calcium and vitamin D supplementation. Br. J. Nutr. 2011, 105:71-79.
13. Eng J. Sample size estimation: how many individuals should be studied?. Radiology 2003, 227:309-313.
14. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1988, 124:869-871.
15. Forman J.P., Scott J.B., Ng K., Drake B.F., Suarez E.G., Hayden D.L., et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 2013, 61:779-785.
16. Fournier T., Medjoubi-N N., Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta 2000, 1482:157-171.
17. Gagnon C., Daly R.M., Carpentier A., Lu Z.X., Shore-Lorenti C., Sikaris K., et al. Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS One 2014, 9:e109607.
18. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., et al. The nuclear vitamin D receptor. Biological and molecular regulatory properties revealed. J. Bone Miner. Res. 1998, 13:325-349.
19. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96:1911-1930.
20. Hopkins M.H., Owen J., Ahearn T., Fedirko V., Flanders W.D., Jones D.P., et al. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev. Res. (Phila.) 2011, 4:1645-1654.
21. Hossein-nezhad A., Holick M.F. Vitamin D for health: a global perspective. Mayo Clin. Proc. 2013, 88:720-755.
22. Judd S.E., Raiser S.N., Kumari M., Tangpricha V. 1,25-Dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study. J. Steroid Biochem. Mol. Biol. 2010, 121:445-447.
23. Keenan N.L., Strogatz D.S., James S.A., Ammerman A.S., Rice B.L. Distribution and correlates of waist-to-hip ratio in black adults: the Pitt County Study. Am. J. Epidemiol. 1992, 135:678-684.
24. Lima F.E.L., Slater B., Latorre M.R.D.O., Fisberg R.M. Validade de um questionário quantitativo de frequência alimentar desenvolvido para população feminina no Nordeste do Brasil. Rev. Bras. Epidemiol. 2007, 10:483-490.
25. Lima F.E.L., Latorre M.R.D.O., Costa M.J.C., Fisberg R.M. Diet and cancer in northeaste Brazil: evaluation of eating habits and food group consuption in relation to breast cancer. Cad. Saude Publica 2008, 24:820-828.
26. Maeda S.S., Borba V.Z., Camargo M.B., Silva D.M., Borges J.L., Bandeira F., et al. Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D. Arq. Bras. Endocrinol. Metabol. 2014, 58:411-433.
27. Matias P.J., Jorge C., Ferreira C., Borges M., Aires I., Amaral T., et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin. J. Am. Soc. Nephrol. 2010, 5:905-911.
28. Mauf S., Penna-Martinez M., Jentzsch T., Ackermann H., Henrich D., Radeke H.H., et al. Immunomodulatory effects of 25-hydroxyvitamin D3 on monocytic cell differentiation and influence of vitamin D3 polymorphisms in type 1 diabetes. J. Steroid Biochem. Mol. Biol. 2014, 147:17-23.
29. Mete T., Yalcin Y., Berker D., Ciftci B., Guven S.F., Topaloglu O., et al. Obstructive sleep apnea syndrome and its association with vitamin D deficiency. J. Endocrinol. Investig. 2013, 36:681-685.
30. Mostowska A., Sajdak S., Pawlik P., Lianeri M., Jagodzinski P.P. Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population. Genet. Test. Mol. Biomarkers 2013, 17:183-187.
31. Nasri H., Behradmanesh S., Ahmadi A., Rafieian-Kopaei M. Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial. J. Nephropathol. 2014, 3:29-33.
32. Neves J.P.R., Silva A.S., Morais L.C.S.L., Diniz A.S., Costa M.J.C., Asciutti L.S.R., et al. Concentrações de 25-hidroxivitamina D: fatores associados e relação com níveis pressóricos em idosos hipertensos. Arq. Bras. Endocrinol. Metabol. 2012, 56:415-422.
33. Neyestani T.R., Djazayery A., Shab-Bidar S., Eshraghian M.R., Kalayi A., Shariátzadeh N., et al. Vitamin D receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care 2013, 36:550-556.
34. Nunan D., Jakovljevic D.G., Donovan G., Hodges L.D., Sandercock D.A.B. Levels of agreement for RR intervals and short-term heart rate variability obtained from the Polar S810 and an alternative system. Eur. J. Appl. Physiol. 2008, 103:529-537.
35. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
36. Pacini S., Punzi T., Gulisano M., Boddi V., Aterini S., Amato M., et al. Vitamin D receptor alleles and C-reactive protein in hemodialysis patients. Ital. J. Anat. Embryol. 2008, 113:55-62.
37. Panierakis C., Goulielmos G., Mamoulakis D., Petraki E., Papavasiliou E., Galanakis E. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin. Immunol. 2009, 133:276-281.
38. Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non diabetic adults. Diabetes Care 2007, 30:980-986.
39. Ponda M.P., Dowd K., Finkielstein D., Holt P.R., Breslow J.L. The short-term effects of vitamin D repletion on cholesterol: a randomized, placebo-controlled trial. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2510-2515.
40. Poon A.H., Gong L., Brasch-Andersen C., Litonjua A.A., Raby B.A., Hamid Q., et al. Very important pharmacogene summary for VDR. Pharmacogenet. Genomics 2012, 22:758-763.
41. Porto L.G.G., Junqueira L.F. Comparison of time-domain short-term heart interval variability analysis using a wrist-worn heart rate monitor and the conventional electrocardiogram. Pacing Clin. Electrophysiol. 2009, 32:43-51.
42. Punzi T., Fabris A., Morucci G., Biagioni P., Gulisano M., Ruggiero M., et al. C-reactive protein levels and vitamin D receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients. Mol. Diagn. Ther. 2012, 16:115-124.
43. Serrano J.C., De Lorenzo D., Cassanye A., Martín-Gari M., Espinel A., Delgado M.A., et al. Vitamin D receptor BsmI polymorphism modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease risk factors profile. Genes Nutr. 2013, 8:561-569.
44. Sharifi N., Amani R., Hajiani E., Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine 2014, 47:70-80.
45. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia-SBC/SBH/SBN VI Diretrizes Brasileiras de Hipertensão Arterial. Arq. Bras. Cardiol. 2010, 95:1-51.
46. Song H.R., Park C.H. Low serum vitamin D level is associated with high risk of metabolic syndrome in post-menopausal women. J. Endocrinol. Investig. 2013, 36:791-796.
47. Szeto F.L., Sun J., Kong J., Duan Y., Liao A., Madara J.L., Li Y.C. Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts. J. Steroid Biochem. Mol. Biol. 2007, 103:563-566.
48. Talaei A., Mohamadi M., Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol. Metab. Syndr. 2013, 5:8.
49. Tarcin O., Yavuz D.G., Ozben B., Telli A., Ogunc A.V., Yuksel M., et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J. Clin. Endocrinol. Metab. 2009, 94:4023-4030.
50. Tellioglu A., Basaran S., Guzel R., Seydaoglu G. Efficacy and safety of high dose intramuscular or oral cholecalciferol in vitamin D deficient/insufficient elderly. Maturitas 2012, 72:332-338.
51. van Schoor N.M., Lips P. Worldwide vitamin D status. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25:671-680.
52. Vuolo L., Di Somma C., Faggiano A., Colao A. Vitamin D and cancer. Front. Endocrinol. (Lausanne) 2012, 3:58.
53. Wiseman H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett. 1993, 326:285-288.
54. Witham M.D., Nadir M.A., Struthers A.D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 2009, 27:1948-1954.
55. Witham M.D., Adams F., Kabir G., Kennedy G., Belch J.J., Khan F. Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK-a randomised controlled trial. Atherosclerosis 2013, 230:293-299.
56. World Health Organization Obesity: preventing and managing the global epidemic. World Health Organ. Tech. Rep. Ser. 1998, 894(i-xii):1-253.
57. Wu S., Liao A.P., Xia Y., Li Y.C., Li J.D., Sartor R.B., Sun J. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am. J. Pathol. 2010, 177(2):686-697. (Aug).
58. Xiao X.H., Liu Z.L., Wang H., Sun Q., Li W.H., Yang G.H., Liu Q.Y. Effects of vitamin D receptor gene polymorphisms on susceptibility to type 1 diabetes mellitus. Chin. Med. Sci. J. 2006, 21:95-98.